Core Viewpoint - The company, which owns The Ordinary and Clinique brands, expects a sales decline of 8% to 9% this year, which is worse than Wall Street's expectations [1] Group 1: Sales and Financial Performance - The anticipated sales decline is attributed to trade turmoil and a challenging economic outlook, exacerbating existing deep-rooted challenges faced by the beauty giant [1] - The company's stock rose by 5% in pre-market trading on Thursday, despite a year-to-date decline of 20% for Estée Lauder, compared to a 5.3% drop in the S&P 500 index [1] Group 2: Strategic Initiatives - The company has indicated early signs that its turnaround plan is showing effectiveness, suggesting potential for recovery if issues are adequately addressed [1] - Recent tariff measures have been implemented to mitigate potential negative impacts related to the economic challenges [1]

Core Points - EssilorLuxottica held its Annual Shareholders' Meeting on April 30, 2025, where all 17 resolutions proposed by the Board of Directors were approved, including a dividend of Euro 3.95 per share for the financial year 2024 [2][10] - The company is focusing on transforming into a leader in med-tech and wearable computing, leveraging its industrial and logistics platform in the optical industry and a unique portfolio of iconic brands [3] - The dividend payment option allows shareholders to receive their final dividend in shares, with the share price set at Euro 222.02 [4][11] Dividend Payment Details - Shareholders can opt for payment of the dividend in newly issued shares from May 9, 2025, to May 30, 2025, with specific instructions for those holding shares in pure registered form [5] - New shares will be admitted for trading on the Euronext Paris market and will carry the same rights as existing shares [6] - The payment of the dividend or delivery of new shares will occur on June 5, 2025, with provisions for rounding down to the nearest whole number of shares if necessary [7][15] Important Dates - The ex-dividend date is set for May 7, 2025, and the record date is May 8, 2025 [12][11] - Shareholders can access a webcast of the Annual Shareholders' Meeting for further information [13]

Core Viewpoint - Estee Lauder is expected to report a significant decline in quarterly earnings and revenues, reflecting a downward revision in analysts' projections over the past month [1][2]. Financial Performance - The anticipated earnings per share (EPS) for Estee Lauder is $0.29, representing a 70.1% decline year over year [1]. - Analysts forecast revenues of $3.51 billion, indicating an 11% decrease compared to the previous year [1]. - The consensus EPS estimate has been revised down by 8.5% over the last 30 days [1]. Sales Projections by Category - Net sales for Skin Care are projected to reach $1.87 billion, down 9.3% year over year [4]. - Makeup net sales are expected to be $1.07 billion, reflecting a 6% decrease from the prior year [4]. - Other net sales are estimated at -$38.46 million, indicating a drastic decline of 247.9% year over year [4]. - Hair Care net sales are forecasted at $134.79 million, down 5.7% from the previous year [5]. - Fragrance net sales are projected to be $574.19 million, showing a slight decrease of 0.1% [5]. - Net sales in The Americas are expected to reach $1.08 billion, down 3.1% year over year [5]. - Sales in Europe, the Middle East & Africa are estimated at $1.40 billion, reflecting a 15.1% decline [6]. - Asia/Pacific net sales are projected at $1.02 billion, indicating a 13.3% decrease [6]. Operating Income Projections - Operating income for Skin Care is expected to be $354.08 million, down from $468 million year over year [6]. - Operating income for Other is projected at -$220.82 million, compared to a positive $11 million last year [7]. - Makeup operating income is estimated at $53.44 million, down from $66 million [7]. - Fragrance operating income is expected to be $17.18 million, compared to $29 million in the previous year [8]. Stock Performance - Estee Lauder shares have decreased by 12.2% over the past month, contrasting with the Zacks S&P 500 composite's decline of only 0.2% [8].

自疫情爆发以来，美妆个护行业的并购活动相比其他行业具有更强的韧性。 2024年美妆个护行业的并 购交易总数量达到了历史新高。 该行业的复苏能力得益于有利的宏观趋势，为其在未来实现可持续增 长以及扩大利润空间提供了支撑。 与X世代和婴儿潮一代相比，千禧一代、Z世代和阿尔法世代更加关注健康和幸福指数，这使得他们 对产品的使用率更高、购买量更大，并且更愿意为产品支付更高的价格，因而持续吸引着投资者的关 注。然而疫情也凸显出了消费者偏好的转变。虽然美妆个护市场的某些领域受到了广泛关注，但其他 领域却面临着挑战，这表明市场分化正在加剧。 对投资者来说未来12到18个月是一个难得的机遇期。 大型跨国公司正面临重新平衡其投资组合的压 力，资产剥离的情况将变得越来越普遍。与此同时，寻求回笼资金的私募股权投资者会处置那些持有 时间较长的资产，这将进一步增加市场上资产的供应。我们预计这将为投资者创造难得的机会，使其 能够以优惠的估值收购资产。 但随着优质资产日益稀缺，同时流动性得以恢复，来自企业和私募股权的竞争可能会引发竞价大战。 对于那些寻求投资组合转型、实现增长并在美妆个护市场占据领先地位的投资者来说，现在正是适合 采取行动 ...

The Estee Lauder Companies Inc. (EL) is likely to register a decline in both top and bottom lines when it reports third-quarter fiscal 2025 earnings on May 1. The Zacks Consensus Estimate for net sales is pegged at $3.5 billion, implying a decrease of 10.9% from the prior-year quarter's level.The consensus mark for fiscal third-quarter earnings has decreased a penny in the past 30 days to 30 cents per share, indicating a decline of 69.1% from the figure reported in the year-ago quarter. EL delivered a trail ...

作为老牌全球美妆巨头，雅诗兰黛的生产地分布在全球范围内，在中国销售的产品主要生产于英国、日 本、加拿大等生产基地，以确保最大程度保证产品供应的灵活。但据国药监进口化妆品注册信息显示， 雅诗兰黛仍有不少产品原产地为美国，比如专研光透焕白精华素、倩碧卓效祛痘凝胶等产品，以及一部 分第5代小棕瓶眼霜、智妍胶原霜等热销产品。 关税政策下，雅诗兰黛部分产品的原材料成本压力陡增。如果将关税成本转嫁至终端，其售价涨幅只高 不低。尽管当前雅诗兰黛的全球供应链布局能够在一定程度削减关税带来的成本上涨，但这些产品仍或 因产线单一，短期内难以转移生产，导致陷入"涨价失销量、不涨损利润"的两难困境。 21世纪经济报道记者易佳颖实习生林耀康上海报道 外资市场风起云涌。 据新华社报道，北京时间4月11日，中方宣布对原产于美国的进口商品加征关税税率提高至125%。国务 院关税税则委员会在公告中明确指出，"鉴于在目前关税水平下，美国输华商品已无市场接受可能性"。 具体到化妆品行业，雅诗兰黛、宝洁、高露洁等多家美国化妆品巨头，面对关税政策的波动，股价和市 值都有较大影响。据中国医药保健品进出口商会统计数据，2024年，美国对华化妆品出口额17 ...

Core Insights - EssilorLuxottica reported consolidated revenue of Euro 6,848 million for Q1 2025, marking a year-on-year increase of 7.3% at constant exchange rates and 8.1% at current exchange rates compared to Q1 2024 [1][4] Revenue Growth - The company's revenue growth was driven by strong performance across all regions and business segments, with comparable-store sales increasing by 8% [4] - EMEA region experienced a growth of 10% at constant exchange rates, supported by both the PS and DTC channels [4] - North America saw a growth of 4%, with solid trends in DTC and resilient demand in PS [4] - Asia-Pacific region reported double-digit growth, particularly strong in myopia solutions in China [4] Product and Brand Performance - The launch of Nuance Audio marked a new category in the U.S., Italy, and France, with plans to expand into the UK and Germany [2][4] - Ray-Ban Meta showed rapid growth, benefiting from high penetration of Transitions lenses [4] - The company highlighted the significance of its brands, including Oakley celebrating its 50th anniversary and Oliver Peoples extending its partnership with Roger Federer [2] Strategic Goals and Future Outlook - The company is making significant strides towards its strategic goals, particularly in the wearables and med-tech space, supported by new clinical data on Stellest for myopia progression [2] - The commitment of the company's 200,000 employees is emphasized as a key factor in driving continued success and shareholder trust [2]

高端美妆产品进口额下降 3%，但在线零售额增长 10% | | 1Q 22 | 2Q 22 | 3Q 22 | 4Q 22 | 1Q 23 | 2Q 23 | 3Q 23 | 4Q 23 | 1Q 24 | 2Q 24 | 3Q 24 | 4Q 24 | 1Q 25 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Sell in | (4)% | (6)% | (11)% | (19)% | (6)% | (23)% | (25)% | (24)% | (21)% | (4)% | (7)% | (4)% | (3)% | | Online sales | 7% | (6)% | (13)% | (26)% | (21)% | (9)% | (21)% | (2)% | (6)% | (3)% | 7% | (8)% | 10 % | | | 1Q 22 | 2Q 22 | 3Q 22 | 4Q 22 | 1Q 23 | 2Q 23 | 3Q 23 | 4Q 23 | 1Q 24 ...

Core Viewpoint - Estee Lauder is well-positioned to continue its earnings-beat streak, with a strong history of surpassing earnings estimates, particularly in the last two quarters, where it achieved an average surprise of 74.65% [1][5]. Earnings Performance - In the last reported quarter, Estee Lauder reported earnings of $0.62 per share, exceeding the Zacks Consensus Estimate of $0.32 per share, resulting in a surprise of 93.75% [2]. - In the previous quarter, the company was expected to earn $0.09 per share but delivered $0.14 per share, achieving a surprise of 55.56% [2]. Earnings Estimates and Predictions - There has been a favorable change in earnings estimates for Estee Lauder, with a positive Earnings ESP of +14.31%, indicating that analysts have recently become more optimistic about the company's earnings prospects [5][8]. - The combination of a positive Earnings ESP and a Zacks Rank of 3 (Hold) suggests a high likelihood of another earnings beat, with historical data showing that stocks with this combination beat estimates nearly 70% of the time [6][8]. Earnings ESP Explanation - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, with the Most Accurate Estimate reflecting the latest analyst revisions, which may be more accurate than earlier predictions [7]. - A negative Earnings ESP can reduce predictive power but does not necessarily indicate an earnings miss [9]. Importance of Earnings ESP - Companies often beat consensus EPS estimates, but this is not the only factor influencing stock price movements. Therefore, checking a company's Earnings ESP before quarterly releases is crucial for increasing the odds of success [10].

Group 1 - The Estée Lauder Companies Inc. has experienced significant challenges for shareholders in recent years, with a notable decline in stock performance since January 2022 [1] - The company was previously described as an "excellent company," indicating a shift in perception due to recent financial difficulties [1]